相关实验视频

Updated: Feb 24, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

成功治疗与SARS-CoV-2感染复杂的多发性骨髓瘤:一个病例报告

Yuna Meng¹, Baoying Duan¹, Lixian Gao¹

¹Department of Hematology, The First People's Hospital of Baiyin, Baiyin, Gansu, China.

Case reports in medicine

|February 23, 2026

概括

患有多发性髓瘤 (MM) 的老年患者容易受到COVID-19的感染. 早期用尼马特里尔维尔/里托纳维尔抗病毒治疗改善了SARS-CoV-2感染的免疫功能低下的MM患者的结果.

科学领域:

血液学血液学血液学
传染性疾病传染性疾病
在瘤学瘤学.

背景情况:

冠状病毒 (COVID-19) 疫情对免疫功能低下的个体构成重大威胁,特别是患有血液性恶性瘤的老年患者.
患有多发性骨髓瘤 (MM) 的患者的免疫系统已经减弱,增加了他们对 SARS-CoV-2 等严重感染的易感性.

研究的目的:

描述感染了SARS-CoV-2感染的多发性骨髓瘤患者的诊断和治疗.
突出早期抗病毒干预对免疫功能低下的癌症患者的重要性.

主要方法:

病例报告详细介绍了一名66岁的男性,新诊断出多发性骨髓瘤.
分析患者信息,临床特征,实验室结果,胸部CT和支气管镜检查结果.
针对SARS-CoV-2感染的涅马特里尔维尔/里托纳维尔治疗.

主要成果:

患者在为多发性骨髓瘤进行化疗后发生了SARS-CoV-2感染.
在开始尼玛特里尔维尔/里托纳维尔治疗后,观察到显著的临床改善.
这个案例强调了MM患者对COVID-19的脆弱性.

结论:

患有多发性骨髓瘤的免疫受损患者面临严重COVID-19的高风险.
早期服用尼尔马特里尔维尔/里托纳维尔等抗病毒药物对于在MM患者中控制SARS-CoV-2至关重要.
积极预防感染和及时干预对于改善结果至关重要.

关键词:

这是一种SARS-CoV-2感染.案例报告案例报告传染病是一种传染性疾病.多发性骨髓瘤是多发性骨髓瘤的一种疾病.尼尔马特雷尔维尔/里托纳维尔片

更多相关视频

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

相关概念视频

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...